Regeneron and MTPC Announce Japanese Collaboration

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a collaboration with Mitsubishi Tanabe Pharma Corporation (TSE: 4508) (MTPC) providing MTPC with exclusive development and commercial rights to fasinumab (REGN475), Regeneron’s NGF antibody in late-stage...

Visit the Biotech CEO Summit 2015

Questions that Cause Biotech CEOs to Lose Sleep: Should I divert funds to the new and promising program or stay focused? Does my team have the skills to take us to the next level? Is our board the right board for the company we want to be? How can I get the best...